Bernd Buchmann

769 total citations
19 papers, 510 citations indexed

About

Bernd Buchmann is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Bernd Buchmann has authored 19 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Bernd Buchmann's work include Cancer Treatment and Pharmacology (9 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Synthetic Organic Chemistry Methods (4 papers). Bernd Buchmann is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Synthetic Organic Chemistry Methods (4 papers). Bernd Buchmann collaborates with scholars based in Germany and United Kingdom. Bernd Buchmann's co-authors include Roland Neuhaus, Hartmut Rehwinkel, Marcus Bauser, Thomas Müller, Hölger Siebeneicher, Iring Heisler, Wolfgang Schwede, Ulrich Klar, Werner Skuballa and Arwed Cleve and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

Bernd Buchmann

18 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernd Buchmann Germany 9 272 183 158 102 69 19 510
Arwed Cleve Germany 10 269 1.0× 76 0.4× 128 0.8× 91 0.9× 46 0.7× 21 547
Andrew McGown United Kingdom 11 325 1.2× 228 1.2× 111 0.7× 107 1.0× 41 0.6× 28 661
Enrica Favini Italy 16 450 1.7× 180 1.0× 100 0.6× 71 0.7× 122 1.8× 23 668
Ayse Batova United States 18 603 2.2× 232 1.3× 174 1.1× 156 1.5× 46 0.7× 28 995
Ruth Freeman Australia 10 562 2.1× 115 0.6× 334 2.1× 90 0.9× 32 0.5× 10 823
Kwang-Rok Kim South Korea 12 382 1.4× 199 1.1× 173 1.1× 57 0.6× 42 0.6× 14 692
Munirah Ahmad Malaysia 15 266 1.0× 328 1.8× 153 1.0× 95 0.9× 56 0.8× 24 601
Angela Maria Di Francesco Italy 13 296 1.1× 207 1.1× 91 0.6× 69 0.7× 20 0.3× 25 567
Dandan Yuan China 17 389 1.4× 243 1.3× 153 1.0× 107 1.0× 79 1.1× 50 792
Heather M. Brechbuhl United States 13 413 1.5× 345 1.9× 156 1.0× 46 0.5× 58 0.8× 17 807

Countries citing papers authored by Bernd Buchmann

Since Specialization
Citations

This map shows the geographic impact of Bernd Buchmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Buchmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Buchmann more than expected).

Fields of papers citing papers by Bernd Buchmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Buchmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Buchmann. The network helps show where Bernd Buchmann may publish in the future.

Co-authorship network of co-authors of Bernd Buchmann

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Buchmann. A scholar is included among the top collaborators of Bernd Buchmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Buchmann. Bernd Buchmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mowat, Jeffrey, Rafael Carretero, Gabriele Leder, et al.. (2024). Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer. Journal of Medicinal Chemistry. 67(19). 17429–17453. 7 indexed citations
2.
Siebeneicher, Hölger, Marcus Bauser, Bernd Buchmann, et al.. (2016). Identification of novel GLUT inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(7). 1732–1737. 40 indexed citations
3.
Siebeneicher, Hölger, Arwed Cleve, Hartmut Rehwinkel, et al.. (2016). Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876. ChemMedChem. 11(20). 2261–2271. 212 indexed citations
4.
Kopitz, Charlotte, Luisella Toschi, Carolyn Algire, et al.. (2016). Abstract 4746: Pharmacological characterization of BAY-876, a novel highly selective inhibitor of glucose transporter (GLUT)-1 in vitro and in vivo. Cancer Research. 76(14_Supplement). 4746–4746. 7 indexed citations
5.
Rennefahrt, Ulrike, Sandra González Maldonado, Alexander M. Walter, et al.. (2015). Abstract 1164: Metabolic responses in cancer cells with differential susceptibility to GLUT1 inhibition. Cancer Research. 75(15_Supplement). 1164–1164. 1 indexed citations
6.
Schueler, Julia, Michael Haerter, Ulf Boemer, et al.. (2014). Abstract 1026: Novel Tie2 inhibitor with in vivo efficacy in disseminated hematological tumor models in mice. Cancer Research. 74(19_Supplement). 1026–1026. 1 indexed citations
7.
Schottelius, Arndt, Ulrich Zügel, Wolf‐Dietrich Döcke, et al.. (2009). The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in the p38/TNF-α Pathway of Systemic and Cutaneous Inflammation. Journal of Investigative Dermatology. 130(2). 481–491. 36 indexed citations
8.
Hammer, Stefanie, Bernd Buchmann, Wolfgang Schwede, et al.. (2008). SAGOPILONE, A NOVEL EPOTHILONE, INHIBITS TUMOR CELL GROWTH IN PRECLINICAL MODELS OF UROLOGICAL CANCER. The Journal of Urology. 179(4S). 479–479. 1 indexed citations
9.
Bonin, Arne von, et al.. (2007). Synthesis of 3H-labeled Efomycine M. Tetrahedron Letters. 48(34). 5984–5986. 4 indexed citations
10.
Klar, Ulrich, Bernd Buchmann, Wolfgang Schwede, et al.. (2006). Total Synthesis and Antitumor Activity of ZK‐EPO: The First Fully Synthetic Epothilone in Clinical Development. Angewandte Chemie International Edition. 45(47). 7942–7948. 92 indexed citations
11.
Hoffman, Justin, Suntrea T.G. Hammer, Bernd Buchmann, et al.. (2006). 631 POSTER Comparative antiproliferative activities and cellular distribution of the third-generation epothilone ZK-EPO and texanes. European Journal of Cancer Supplements. 4(12). 190–190. 1 indexed citations
12.
Klar, Ulrich, Bernd Buchmann, Wolfgang Schwede, et al.. (2006). Total Synthesis and Antitumor Activity of ZK‐EPO: The First Fully Synthetic Epothilone in Clinical Development. Angewandte Chemie. 118(47). 8110–8116. 18 indexed citations
13.
Hoffmann, Jens, Bernd Buchmann, Wolfgang Schwede, et al.. (2005). New synthetic Epothilone Derivative ZK-EPO inhibits breast cancer metastasis. Cancer Research. 65. 807–807. 6 indexed citations
14.
Klar, Ulrich, et al.. (2005). Efficient Chiral Pool Synthesis of the C1-C6 Fragment of Epothilones. Synthesis. 2005(2). 301–305. 18 indexed citations
15.
Klar, Ulrich, Werner Skuballa, Bernd Buchmann, et al.. (2002). ChemInform Abstract: Synthesis and Biological Activity of Epothilones. ChemInform. 33(25). 6 indexed citations
16.
Lichtner, Rosemarie B., T. Bunte, Bernd Buchmann, et al.. (2001). Subcellular distribution of epothilones in human tumor cells. Proceedings of the National Academy of Sciences. 98(20). 11743–11748. 32 indexed citations
17.
Buchmann, Bernd, et al.. (1991). The role of leukotriene B4 as an inflammatory mediator in skin and the functional characterisation of LTB4 receptor antagonists.. PubMed. 21B. 565–8. 1 indexed citations
18.
Weyerstahl, Peter, et al.. (1988). Struktur und Geruch, VII. Synthese und olfaktorische Eigenschaften von Theaspiran‐Analoga. Liebigs Annalen der Chemie. 1988(6). 507–523. 19 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arwed Cleve Breakdown of academic impact, for papers by Andrew McGown Breakdown of academic impact, for papers by Enrica Favini Breakdown of academic impact, for papers by Ayse Batova Breakdown of academic impact, for papers by Ruth Freeman Breakdown of academic impact, for papers by Kwang-Rok Kim Breakdown of academic impact, for papers by Munirah Ahmad Breakdown of academic impact, for papers by Angela Maria Di Francesco Breakdown of academic impact, for papers by Dandan Yuan Breakdown of academic impact, for papers by Heather M. Brechbuhl
Rankless by CCL
2026